tiprankstipranks
Trending News
More News >
Axsome Therapeutics Inc (AXSM)
NASDAQ:AXSM

Compare Axsome Therapeutics (AXSM) vs. Competitors

Compare
2,311 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Axsome Therapeutics
$177.27
$8.94B
-37.93
89.21%
14 Buy
1 Hold
0 Sell
Strong Buy
Cytokinetics
$62.58
$7.65B
-9.92
33.18%
15 Buy
2 Hold
0 Sell
Strong Buy
Rhythm Pharmaceuticals
$101.63
$6.78B
-32.75
85.93%
14 Buy
1 Hold
0 Sell
Strong Buy
Legend Biotech
$22.14
$4.09B
-29.56%
10 Buy
1 Hold
0 Sell
Strong Buy
Avidity Biosciences
$72.51
$10.93B
-17.39
156.31%
2 Buy
11 Hold
0 Sell
Hold
Nuvalent
$104.26
$7.58B
-19.61
37.20%
17 Buy
0 Hold
0 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
AXSM
Axsome Therapeutics
177.27
81.09
84.31%
CYTK
Cytokinetics
62.58
16.76
36.58%
RYTM
Rhythm Pharmaceuticals
101.63
44.11
76.69%
LEGN
Legend Biotech
22.14
-12.53
-36.14%
RNA
Avidity Biosciences
72.51
41.67
135.12%
NUVL
Nuvalent
104.26
25.98
33.19%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts